{
    "id": "62015485c9dfcb9c09000023",
    "question": "Do SETD1A mutations predispose to schizophrenia?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the provided documents to find any information related to SETD1A mutations and their association with schizophrenia. SETD1A is a gene that has been studied for its potential role in various neurological disorders, including schizophrenia. However, the provided documents do not explicitly mention SETD1A mutations as a risk factor for schizophrenia. That being said, we can look for connections between SETD1A and other conditions that may be related to schizophrenia. For example, SETD1A has been associated with intellectual disability and autism spectrum disorder (ASD), which are conditions that often co-occur with schizophrenia. Additionally, SETD1A mutations have been linked to neurodevelopmental disorders, which is consistent with the neurodevelopmental nature of schizophrenia. Despite these connections, there is no direct evidence in the provided documents to suggest that SETD1A mutations predispose to schizophrenia. Therefore, the answer is not explicitly supported by the provided documents.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_31590",
            "title": "InternalMed_Harrison",
            "content": "T-box, brain 1 Signal transduction Synaptic function Signal transduction Translation and protein stability Synaptic function Signal transduction Translation and protein stability Synaptic function Signal transduction with multiple psychiatric syndromes. For example, mutations in MECP2, FMR1, and TSC1 and TSC2 (see Table 465e-1 for abbreviations) can cause mental retardation without ASD, others in MECP2 can cause obsessive-compulsive and attention-deficit hyperactivity disorders, some alleles of NRXN1 are associated with symptoms of both ASD and schizophrenia, and common polymorphisms in CACNA1C are strongly associated with both schizophrenia and bipolar disorder. Likewise, duplication of chromosome 16p is associated with both schizophrenia and autism, whereas DiGeorge\u2019s (velocardiofacial) syndrome region deletions and the DISC1 (disrupted in schizophrenia 1) locus on chromosome 22 are associated with schizophrenia, autism, and bipolar disorder. The association of genes with multiple"
        },
        {
            "id": "Obstentrics_Williams_8527",
            "title": "Obstentrics_Williams",
            "content": "Schizophrenia has a major genetic component, and there is a 50-percent concordance in monozygotic twins. If one parent has schizophrenia, the risk to ofspring is 5 to 10 percent. Some data, including a strong association between schizophrenia and the velocardiofacial syndrome, suggest that associated genes are located on chromosome 22q 11 (Murphy, 2002). But sophisticated gene mapping studies clearly show that schizophrenia is not related to a single gene or mutation. Instead, multiple DNA variants likely interact to lead to schizophrenia (Kukshal, 2012). Other putative risks for subsequent schizophrenia in an exposed fetus include maternal iron-deiciency anemia, diabetes, and acute maternal stress (Insel, 2008; Malaspina, 2008; Van Lieshout, 2008). hese remain unproven, as does the association with maternal inluenza A infection."
        },
        {
            "id": "Cell_Biology_Alberts_2389",
            "title": "Cell_Biology_Alberts",
            "content": "In contrast to polymorphisms, rare DNA variants\u2014those much less frequent in humans than SNPs\u2014can have large effects on the risk of developing some common diseases. For example, a number of different loss-of-function mutations, each individually rare, have been found to increase greatly the predisposition to autism and schizophrenia. Many of these are de novo mutations, which arose spontaneously in the germ-line cells of one or the other parent. The fact that these mutations arise spontaneously with some frequency could help explain why these common disorders\u2014each observed in about 1% of the population\u2014remain with us, even though the affected individuals leave few or no descendants. These rare mutations may arise in any one of hundreds of different genes, which could explain much of the clinical variability of autism and schizophrenia. Because they are kept rare by natural selection, most such variants with a large effect on risk would be missed by genome-wide association studies."
        },
        {
            "id": "Pharmacology_Katzung_3106",
            "title": "Pharmacology_Katzung",
            "content": "Schizophrenia is considered to be a neurodevelopmental disorder. This implies that structural and functional changes in the brain are present even in utero in some patients, or that they develop during childhood and adolescence, or both. Twin, adoption, and family studies have established that schizophrenia is a genetic disorder with high heritability. No single gene is involved. Current theories involve multiple genes with common and rare mutations, including large deletions and insertions (copy number variations), combining to produce a very variegated clinical presentation and course."
        },
        {
            "id": "Neurology_Adams_12297",
            "title": "Neurology_Adams",
            "content": "More recently, a hypothesis based on changes in the serotoninergic system has been again proposed. As with the dopaminergic model, attention was drawn to mechanisms relating to a new class of antipsychotics (clozapine, risperidone), which have major effects on the serotonin system and were found to ameliorate the psychosis. Several groups have reported alterations in serotonin receptors in the brains of schizophrenic patients (see later). A further connection is based on the finding by Williams and colleagues of an allelic variation in the gene on chromosome 13 encoding for a serotonin receptor (5-HT2A) that confers a susceptibility to schizophrenia. The variation in this gene is insufficient to explain the presence of the disease in any one individual, if for no other reason than that many patients who are homozygous for the suspect allele do not develop schizophrenia. Perhaps a nearby region relating to the receptor may be at fault through linkage disequilibrium (see commentary by"
        },
        {
            "id": "InternalMed_Harrison_31591",
            "title": "InternalMed_Harrison",
            "content": "syndrome region deletions and the DISC1 (disrupted in schizophrenia 1) locus on chromosome 22 are associated with schizophrenia, autism, and bipolar disorder. The association of genes with multiple syndromes attests to the complexity of psychiatric disorders and the influence of additional factors that combine to specify the ultimate phenotype, including regulatory variants that determine cell-type specificity and timing of gene expression, protective variants, and epigenetic effects."
        },
        {
            "id": "InternalMed_Harrison_31588",
            "title": "InternalMed_Harrison",
            "content": "The ability to catalog common genetic variants and assay them on array-based platforms and, more recently, to carry out whole-exome sequencing has allowed investigators to collect sample sizes sufficient to detect genetic risk loci for schizophrenia with genome-wide significance. Several of the identified genes are parts of molecular complexes, such as voltage-gated calcium channels (in particular, CACNA1C and CACNB2) and the postsynaptic density of excitatory synapses. As in ASDs, copy number variants, single-nucleotide polymorphisms, and small insertions and deletions are common in schizophrenia. Genes that promote risk for drug addiction have also begun to emerge from large family and population studies. The best-established susceptibility loci are regions on chromosomes 4 and 5 containing GABAA receptor gene clusters linked to alcoholism and the CHRNA5-A3-B4 nicotinic acetylcholine receptor gene cluster on chromosome 15 associated with nicotine and alcohol addiction."
        },
        {
            "id": "InternalMed_Harrison_31589",
            "title": "InternalMed_Harrison",
            "content": "A recurrent theme that has emerged from genetic studies of psychiatric disorders is pleiotropy, namely, that many genes are associated Chapter 465e Biology of Psychiatric Disorders Sodium channel, voltage-gated, type I, alpha subunit Sodium channel, voltage-gated, type II, alpha subunit exchanger Glutamate receptor, ionotropic, N-methyl-Daspartate 2B"
        },
        {
            "id": "InternalMed_Harrison_31585",
            "title": "InternalMed_Harrison",
            "content": "Amid this genetic heterogeneity, however, some common themes have emerged that inform pathogenesis of ASDs. For instance, many identified mutations are in genes that encode proteins involved in synaptic function and early transcriptional regulation (Table 465e-1) and have a clear relationship to activity-dependent neural responses that can affect the development of neural systems underlying cognition and social behaviors. Mutations in these genes may be detrimental by altering the balance of excitatory versus inhibitory synaptic signaling in local and extended circuits and by altering mechanisms that control brain growth. Some mutations affect genes (e.g., PTEN, TSC1, and TSC2) that negatively regulate signaling from several types of extracellular stimuli, including those transduced by receptor tyrosine kinases. Their dysregulation can alter neuronal growth as well as synaptic development and function."
        },
        {
            "id": "Psichiatry_DSM-5_544",
            "title": "Psichiatry_DSM-5",
            "content": "Genetic and physiological. There is a strong contribution for genetic factors in deter- mining risk for schizophrenia, although most individuals who have been diagnosed with schizophrenia have no family history of psychosis. Liability is conferred by a spectrum of risk alleles, common and rare, with each allele contributing only a small fraction to the to- tal population variance. The risk alleles identified to date are also associated with other mental disorders, including bipolar disorder, depression, and autism spectrum disorder. Pregnancy and birth complications with hypoxia and greater paternal age are associated with a higher risk of schizophrenia for the developing fetus. In addition, other prenatal and perinatal adversities, including stress, infection, malnutrition, maternal diabetes, and other medical conditions, have been linked with schizophrenia. However, the vast major- ity of offspring with these risk factors do not develop schizophrenia."
        },
        {
            "id": "Neurology_Adams_12295",
            "title": "Neurology_Adams",
            "content": "system gives rise to the positive symptoms of schizophrenia\u2014that is, psychosis\u2014whereas a diminished activity in the mesocortical system accounts for the negative symptoms. The involvement of the mesolimbic system, which plays a role in attention, has prompted further speculation that the thought disorder of schizophrenia is attributable to a breakdown of the normal \u201cfiltering\u201d of stimuli reaching cognition. As mentioned earlier, it has been found that a variant in the gene for COMT that enhances metabolism of dopamine is overrepresented in schizophrenia, further incriminating a disorder of dopaminergic neurotransmission in the pathophysiology of this disease (Egan et al)."
        },
        {
            "id": "Pediatrics_Nelson_432",
            "title": "Pediatrics_Nelson",
            "content": "Childhood-onset schizophrenia is a rare disorder (<1 in 10,000 children) and usually indicates a more severe form of schizophrenia. The frequency increases between 13 and 18 years of age. Boys tend to be affected about twice as often as girls, regardless of ethnic or other cultural factors. The etiology of schizophrenia is unknown. Numerous studies have shown genetic predisposition and linkages for the disorder. In addition, family studies consistently show a higher risk in monozygotic twins compared with dizygotic twins and siblings. First-degree relatives of patients with schizophrenia have a 10-fold higher risk. The symptoms of schizophrenia typically fall into four broad categories: \u2022 Positive symptoms include hallucinations and delusions. Hallucinations are auditory or visual misperceptions that occur without external stimuli. Delusions are fixed false"
        },
        {
            "id": "Neurology_Adams_12298",
            "title": "Neurology_Adams",
            "content": "patients who are homozygous for the suspect allele do not develop schizophrenia. Perhaps a nearby region relating to the receptor may be at fault through linkage disequilibrium (see commentary by Harrison and Geddes). A third currently favored biochemical hypothesis derives from the psychosis syndrome produced by chronic ingestion of phencyclidine (PCP), an N-methyl-d-aspartate (NMDA) antagonist. This implicates the glutaminergic system, but it must be pointed out that the dopaminergic and glutaminergic systems converge on certain cortical neurons and that glutaminergic release is modulated in several places in the brain by dopamine. These various neurochemical hypotheses are summarized by Lieberman and First."
        },
        {
            "id": "InternalMed_Harrison_31584",
            "title": "InternalMed_Harrison",
            "content": "in dizygotic twins and siblings, whereas first-degree relatives show about 50-fold increased risk compared with the general population. ASDs are also genetically heterogeneous. More than 100 known mutations account for up to 20% of cases, although none individually accounts for more than 1% (Table 465e-1). It appears that most cases result from complex genetic mechanisms, including inheritance of multiple genetic risk variants and epigenetic modifications. For example, up to 10% of patients with autism have large (>500 kb) de novo copy number variations scattered across the genome, suggesting that hundreds of different genes can influence autism risk."
        },
        {
            "id": "Neurology_Adams_12265",
            "title": "Neurology_Adams",
            "content": "Subtypes of Schizophrenia"
        },
        {
            "id": "Neurology_Adams_8348",
            "title": "Neurology_Adams",
            "content": "The elucidation of microdeletions and microduplications within chromosome 16p by Weiss and colleagues, working with the Autism Consortium was the first hint of a genetic locus for susceptibility to autism. Despite a high degree of penetrance in individuals with these changes, the importance of these findings is as a biologic direction for research as it explains no more than 1 percent of cases. Furthermore, certain polymorphisms, particularly in the SHANK3 gene may explain a small number of cases. Shank proteins serve as scaffolds on the post-synaptic membranes of glutamatergic synapses, and are highly expressed in the striatum. This gene has variants that appear disproportionately often in schizophrenia as well, leading to speculation on common biologic processes."
        },
        {
            "id": "InternalMed_Harrison_31581",
            "title": "InternalMed_Harrison",
            "content": "Despite these limitations, the past decade has seen significant advances. Neuroimaging methods are beginning to provide evidence of brain pathology, genome-wide association studies and high-throughput sequencing are at last revealing genes that confer risk for severe forms of mental illness, and investigations using better validated animal models are offering new insight into the molecular, cellular, and circuit mechanisms of disease pathogenesis. There is also excitement in the potential utility of neuron-like cells induced in vitro from a patient\u2019s peripheral tissues (e.g., fibroblasts) providing novel ways of studying disease pathophysiology and screening for new treatments. There is consequently justified optimism that the field of psychiatry will transition from behaviorally defined syndromes to true biologic disease entities and that such advances will drive the development of improved treatments and eventually cures and preventive measures. This chapter describes several"
        },
        {
            "id": "Psichiatry_DSM-5_573",
            "title": "Psichiatry_DSM-5",
            "content": "Genetic and physiological. Among individuals with schizophrenia, there may be an in- creased risk for schizoaffective disorder in first-degree relatives. The risk for schizoaffec- schizophrenia, bipolar disorder, or schizoaffective disorder. Cultural and socioeconomic factors must be considered, particularly when the individual and the clinician do not share the same cultural and economic background. Ideas that ap- pear to be delusional in one culture (e.g., witchcraft) may be commonly held in another. There is also some evidence in the literature for the overdiagnosis of schizophrenia com- pared with schizoaffective disorder in African American and Hispanic populations, so care must be talgen to ensure a culturally appropriate evaluation that includes both psy- chotic and affective symptoms."
        },
        {
            "id": "Neurology_Adams_12364",
            "title": "Neurology_Adams",
            "content": "Liddle PF: The symptoms of chronic schizophrenia: A re-examination of the positive-negative dichotomy. Br J Psychiatry 151:145, 1987. Liddle PF, Barnes TRE: Syndromes of chronic schizophrenia. Br J Psychiatry 157:558, 1990. Lieberman JA, First MB: Psychotic disorders. N Engl J Med 379:270, 2018. Lieberman JA, Stroup TS, McEvoy JP, et al: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209, 2005. Manschreck TC: Delusional disorder and shared psychotic disorder. In: Sadock BJ, Sadock VA (eds): Kaplan and Sadock\u2019s Comprehensive Textbook of Psychiatry, 7th ed. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 1243\u20131264. McClellan J, King M-C: Genomic analysis of mental illness. A changing landscape. JAMA 303:2523, 2011. Meltzer HY, Nash JF: Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43:587, 1991."
        },
        {
            "id": "Neurology_Adams_12367",
            "title": "Neurology_Adams",
            "content": "Shenton ME, Kikinis R, Jolesz FA, et al: Abnormalities of the left temporal lobe and thought disorder in schizophrenia. N Engl J Med 327:604, 1992. Silbersweig DA, Stern E, Frith C, et al: A functional neuroanatomy of hallucinations in schizophrenia. Nature 378:176, 1995. Spielmeyer W: The problem of the anatomy of schizophrenia. J Nerv Ment Dis 72:241, 1930. Stevens JR: An anatomy of schizophrenia? Arch Gen Psychiatry 29:177, 1973. Stewart DE: Depression during pregnancy. N Engl J Med 365:1605, 2011. Suddath RL, Christison GW, Torrey EF, et al: Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 322:789, 1990. Taylor MA: Schneiderian first-rank symptoms and clinical prognostic features in schizophrenia. Arch Gen Psychiatry 26:64, 1972."
        },
        {
            "id": "Neurology_Adams_12244",
            "title": "Neurology_Adams",
            "content": "Clinical Syndrome of Schizophrenia"
        },
        {
            "id": "Psichiatry_DSM-5_329",
            "title": "Psichiatry_DSM-5",
            "content": "Schizophrenia. Schizophrenia with childhood onset usually develops after a period of normal, or near normal, development. A prodromal state has been described in which so- cial impairment and atypical interests and beliefs occur, which could be confused with the social deficits seen in autism spectrum disorder. Hallucinations and delusions, which are defining features of schizophrenia, are not features of autism spectrum disorder. How- ever, clinicians must take into account the potential for individuals with autism spectrum disorder to be concrete in their interpretation of questions regarding the key features of schizophrenia (e.g., \u201dDo you hear voices when no one is there?\u201d \u201dYes [on the radio]\u201d)."
        },
        {
            "id": "Neurology_Adams_7483",
            "title": "Neurology_Adams",
            "content": "Multifactorial genetic diseases may also be familial. They may present as constitutional disorders with gene abnormalities located on several chromosomes (polygenic, or \u201ccomplex genetics\u201d) or may arise from single nucleotide polymorphisms or copy number variations. Here, the relative contributions of genetic and environmental influences are highly variable. The occurrence of many disorders that display high degrees of familial incidence, such as schizophrenia and Gilles de la Tourette syndrome, but do not strictly conform to classic genetic principles has been attributed to this type of complex genetics. The separation of metabolic-genetic from degenerative diseases (accorded a separate chapter) may disquiet the reader, for there are many overlaps between the two groups. The current division is tenable only until such time as all the degenerative diseases will have been shown to have a comprehensible pathogenesis. The Genetics of Mitochondrial Disease"
        },
        {
            "id": "Pediatrics_Nelson_441",
            "title": "Pediatrics_Nelson",
            "content": "Residual type: clinical situation in which full diagnostic criteria have been met previously but no current, prominent, positive symptoms. To meet criteria for diagnosing schizophrenia, clinical symptoms should be present for at least 6 months. If symptoms are present for less than 1 month, the condition is called a brief psychotic disorder. If symptoms are present for more than 1 month but less than 6 months, a diagnosis of schizophreniform disorder is made. Psychotic symptoms that do not meet full diagnostic criteria for schizophrenia but are clinically significant are diagnosed as psychotic disorder not otherwise specified. There are several disorders that have to be distinguished from schizophrenia. These include the following: Schizoaffective disorder is diagnosed when a person has clear symptoms of schizophrenia for at least 2 weeks without active symptoms of depression or mania. These affective syndromes occur at other times, even when psychotic symptoms are present."
        },
        {
            "id": "InternalMed_Harrison_31583",
            "title": "InternalMed_Harrison",
            "content": "Because the human brain can only be examined indirectly during life, genome analyses have been extremely important for obtaining molecular clues about the pathogenesis of psychiatric disorders. A wealth of new information has been made possible by recent technological developments that have permitted affordable, large-scale genome-wide association studies and fine-scale sequencing. As an example, significant progress has been made in the genetics of autism spectrum disorders (ASDs), which are a heterogeneous group of neurodevelopmental diseases that share clinical features of impaired reciprocal social communication and interaction and restricted, repetitive patterns of behavior. ASDs are highly heritable; concordance rates in monozygotic twins (~60\u201390%) are roughly 10-fold higher than in dizygotic twins and siblings, whereas first-degree relatives show about 50-fold increased risk compared with the general population. ASDs are also genetically heterogeneous. More than 100 known"
        },
        {
            "id": "InternalMed_Harrison_29614",
            "title": "InternalMed_Harrison",
            "content": "There is optimism that complex genetic disorders, caused by combinations of both genetic and environmental factors, have now become tractable problems. Genome-wide association studies (GWAS) have been carried out in many complex neurologic disorders, with many hundreds of variants identified, nearly all of which confer only a small increment in disease risk (1.15to 1.5-fold). GWAS studies are rooted in the \u201ccommon disease, common variant\u201d hypothesis, as they examine potential risk alleles that are relatively frequent (e.g. >5%) in the general population. More than 1500 GWAS studies have been carried out, with notable successes such as the identification of 110 risk alleles for multiple sclerosis (Chap. 458). Furthermore, using bioinformatics tools, risk variants can be aligned in functional biologic pathways to identify novel pathogenic mechanisms as well as to reveal heterogeneity (e.g., different pathways in different individuals). Despite these successes, many experienced"
        },
        {
            "id": "Obstentrics_Williams_1754",
            "title": "Obstentrics_Williams",
            "content": "his is the most common inherited form of intellectual disability and afects approximately 1 in 3600 males and 1 in 4000 to 6000 females (American College of Obstetricians and Gynecologists, 2017a). Fragile X syndrome is caused by expansion TABLE 13-4. Some Disorders Caused by DNA Triplet Repeat Expansion of a repeated trinucleotide DNA segment-cytosine-guanineguanine (CGG)-at chromosome Xq27.3. When the CGG repeat number reaches a critical size-the full mutation-the ragile X mental retardation 1 (FMR1) gene becomes methyl ated. Methylation inactivates the gene, which halts expression of FMR1 protein. his protein is most abundant in nerve cells and is essential for normal cognitive development."
        },
        {
            "id": "InternalMed_Harrison_27413",
            "title": "InternalMed_Harrison",
            "content": "Testicular morphology, semen production, and fertility are maintained up to a very old age in men. Although concern has been expressed about age-related increases in germ cell mutations and impairment of DNA repair mechanisms, there is no clear evidence that the frequency of chromosomal aneuploidy is increased in the sperm of older men. However, the incidence of autosomal dominant diseases, such as achondroplasia, polyposis coli, Marfan\u2019s syndrome, and Apert\u2019s syndrome, increases in the offspring of men who are advanced in age, consistent with transmission of sporadic missense mutations. Advanced paternal age may be associated with increased rates of de novo mutations, which may contribute to an increased risk of neurodevelopmental diseases such as schizophrenia and autism. The somatic mutations in male germ cells that enhance the proliferation of germ cells could lead to within-testis expansion of mutant clonal lines, thus favoring the propagation of germ cells carrying these"
        },
        {
            "id": "Psichiatry_DSM-5_554",
            "title": "Psichiatry_DSM-5",
            "content": "Rates of comorbidity with substance-related disorders are high in schizophrenia. Over half of individuals with schizophrenia have tobacco use disorder and smoke cigarettes regularly. Comorbidity with anxiety disorders is increasingly recognized in schizophre- nia. Rates of obsessive-compulsive disorder and panic disorder are elevated in individuals with schizophrenia compared with the general population. Schizotypal or paranoid per- sonality disorder may sometimes precede the onset of schizophrenia. Life expectancy is reduced in individuals with schizophrenia because of associated medical conditions. Weight gain, diabetes, metabolic syndrome, and cardiovascular and pulmonary disease are more common in schizophrenia than in the general population."
        },
        {
            "id": "InternalMed_Harrison_31811",
            "title": "InternalMed_Harrison",
            "content": "characteristics that subsequently combine with environmental influences to alter the risk for heavy drinking and alcohol problems. These include genes relating to a high risk for all substance use disorders that operate through impulsivity, schizophrenia, and bipolar disorder. Another characteristic, an intense flushing response when drinking, decreases the risk for only alcohol use disorders through gene variations for several alcohol-metabolizing enzymes, especially aldehyde dehydrogenase (a mutation only seen in Asians), and to a lesser extent, variations in ADH."
        },
        {
            "id": "InternalMed_Harrison_29760",
            "title": "InternalMed_Harrison",
            "content": "CHRNA4 (20q13.2) Nicotinic acetylcholine receptor subunit; mutations cause alterations in Ca2+ flux through the receptor; this may reduce amount of GABA release in presynaptic terminals KCNQ2 (20q13.3) Voltage-gated potassium channel subunits; mutation in pore regions may cause a 20\u201340% reduction of potassium currents, which will lead to impaired repolarization SCN1A (2q24.3) \u03b1-Subunit of a voltage-gated sodium channel; numerous mutations affecting sodium currents that cause either gain or loss of function; network effects appear related to expression in excitatory or inhibitory cells LGI1 (10q24) Leucine-rich glioma-inactivated 1 gene; previous evidence for role in glial tumor progression; recent studies suggest an influence in the postnatal development of glutamatergic circuits in the hippocampus"
        },
        {
            "id": "InternalMed_Harrison_29791",
            "title": "InternalMed_Harrison",
            "content": "contrast, gene mutations observed in symptomatic epilepsies (i.e., disorders in which other neurologic abnormalities such as cognitive impairment coexist with seizures) are proving to be associated with pathways influencing CNS development or neuronal homeostasis. De novo mutations may explain a significant proportion of these syndromes, especially those with onset in early childhood. A current challenge is to identify the multiple susceptibility genes that underlie the more common forms of idiopathic epilepsies. Recent studies suggest that ion channel mutations and copy number variants may contribute to causation in a subset of these patients."
        }
    ],
    "scores": [
        0.03728367031187879,
        0.035945129039758196,
        0.033933274802458294,
        0.03301665051646267,
        0.032727869332684886,
        0.02941736481340442,
        0.027565256090245932,
        0.026554692524612875,
        0.025079872659752443,
        0.02482603411200598,
        0.022097420769987143,
        0.021679053204655414,
        0.020134561001434067,
        0.018255746411086217,
        0.0179549114331723,
        0.017812105926860028,
        0.017721320473614053,
        0.017331932773109245,
        0.017011197243755383,
        0.016935310552331828,
        0.016865079365079364,
        0.016592171204117566,
        0.01644736842105263,
        0.016368556530922052,
        0.016264462809917356,
        0.016145371660124096,
        0.01602809706257982,
        0.015686515748031496,
        0.015455864300859278,
        0.015176419022572867,
        0.015061238000662032,
        0.015058876811594204
    ]
}